| Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report J Giandhari, S Pillay, E Wilkinson, H Tegally, I Sinayskiy, M Schuld, ... International Journal of Infectious Diseases 103, 234-241, 2021 | 108 | 2021 |
| Whole genome sequencing of SARS-CoV-2: adapting Illumina protocols for quick and accurate outbreak investigation during a pandemic S Pillay, J Giandhari, H Tegally, E Wilkinson, B Chimukangara, R Lessells, ... Genes 11 (8), 949, 2020 | 89 | 2020 |
| Next generation sequencing and bioinformatics analysis of family genetic inheritance AM Kanzi, JE San, B Chimukangara, E Wilkinson, M Fish, V Ramsuran, ... Frontiers in Genetics 11, 544162, 2020 | 81 | 2020 |
| Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis B Chimukangara, RJ Lessells, SY Rhee, J Giandhari, ABM Kharsany, ... EClinicalMedicine 9, 26-34, 2019 | 73 | 2019 |
| Clinical, virologic, immunologic outcomes and emerging HIV drug resistance patterns in children and adolescents in public ART care in Zimbabwe AT Makadzange, M Higgins-Biddle, B Chimukangara, R Birri, M Gordon, ... PloS one 10 (12), e0144057, 2015 | 71 | 2015 |
| Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase MJ Siedner, MA Moorhouse, B Simmons, T de Oliveira, R Lessells, ... Nature communications 11 (1), 5922, 2020 | 67 | 2020 |
| HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance N Mbhele, B Chimukangara, M Gordon International journal of antimicrobial agents 57 (5), 106343, 2021 | 66 | 2021 |
| Transmission dynamics of SARS-CoV-2 within-host diversity in two major hospital outbreaks in South Africa JE San, S Ngcapu, AM Kanzi, H Tegally, V Fonseca, J Giandhari, ... Virus Evolution 7 (1), veab041, 2021 | 37 | 2021 |
| Moderate-to-high levels of pretreatment HIV drug resistance in KwaZulu-Natal Province, South Africa B Chimukangara, ABM Kharsany, RJ Lessells, K Naidoo, SY Rhee, ... AIDS research and human retroviruses 35 (2), 129-138, 2019 | 28 | 2019 |
| HIV-1 drug resistance genotyping in resource limited settings: current and future perspectives in sequencing technologies S Manyana, L Gounder, M Pillay, J Manasa, K Naidoo, B Chimukangara Viruses 13 (6), 1125, 2021 | 20 | 2021 |
| A simple phosphate-buffered-saline-based extraction method improves specificity of HIV viral load monitoring using dried blood spots AT Makadzange, FK Boyd, B Chimukangara, C Masimirembwa, ... Journal of clinical microbiology 55 (7), 2172-2179, 2017 | 18 | 2017 |
| Primary HIV-1 Drug-Resistant Minority Variants. B Chimukangara, R Samuel, K Naidoo, T de Oliveira AIDS reviews 19 (2), 2017 | 15 | 2017 |
| High resolution analysis of transmission dynamics of Sars-Cov-2 in two major hospital outbreaks in South Africa leveraging intrahost diversity S Ngcapu, AM Kanzi, H Tegally, V Fonseca, J Giandhari, E Wilkinson, ... MedRxiv, 2020 | 14 | 2020 |
| Recurrent tuberculosis among HIV co-infected patients: a case series from KwaZulu-Natal K Naidoo, N Dookie, K Naidoo, N Yende-Zuma, B Chimukangara, ... Infection and drug resistance, 1413-1421, 2018 | 14 | 2018 |
| HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral therapy in KwaZulu-Natal Province, South Africa B Chimukangara, RJ Lessells, B Sartorius, L Gounder, S Manyana, ... Journal of Global Antimicrobial Resistance 29, 468-475, 2022 | 13 | 2022 |
| Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals B Chimukangara, J Giandhari, R Lessells, N Yende-Zuma, B Sartorius, ... Journal of Antimicrobial Chemotherapy 75 (11), 3319-3326, 2020 | 12 | 2020 |
| Community based antiretroviral treatment in rural Zimbabwe B Chimukangara, J Manasa, R Mitchell, G Nyabadza, D Katzenstein, ... AIDS research and human retroviruses 33 (12), 1185-1191, 2017 | 12 | 2017 |
| Adherence measured using electronic dose monitoring is associated with emergent antiretroviral resistance and poor outcomes in people with human immunodeficiency Virus/AIDS and … M Bateman, A Wolf, B Chimukangara, JCM Brust, R Lessells, R Amico, ... Clinical Infectious Diseases 75 (9), 1489-1496, 2022 | 9 | 2022 |
| Whole genome sequencing of SARS-CoV-2: adapting Illumina protocols for quick and accurate outbreak investigation during a pandemic. Genes (Basel) 11: 949 S Pillay, J Giandhari, H Tegally, E Wilkinson, B Chimukangara, R Lessells, ... | 8 | 2020 |
| HIV drug resistance testing among patients failing second line antiretroviral therapy. Comparison of in-house and commercial sequencing B Chimukangara, B Varyani, T Shamu, J Mutsvangwa, J Manasa, E White, ... Journal of virological methods 243, 151-157, 2017 | 7 | 2017 |
